Intriguingly, anti-tumor activity was lost when anti-CD40 was eliminated together with either anti-CTLA-4 or CpG, while some anti-tumor activity was retained when the anti-CTLA-4 and CpG were both eliminated (Figure 3). This evidence concerns the gene CTLA4 and neoplasm.